UNLIMITED TURBO LONG - MERCK & CO. Stock

Certificat

P25143

NLBNPIT25143

Real-time Borsa Italiana 09:37:58 2024-07-08 EDT
1.182 EUR +6.68% Intraday chart for UNLIMITED TURBO LONG - MERCK & CO.
Date Price Change
24-07-08 1.182 +6.68%
24-07-05 1.108 +6.03%
24-07-04 1.045 -5.34%

Real-time Borsa Italiana

Last update July 08, 2024 at 09:37 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
P25143
ISINNLBNPIT25143
Date issued 2024-07-03
Strike 122 $
Maturity Unlimited
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.383
Lowest since issue 0.971
Spread 0.108
Spread %8.74%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus
  1. Stock Market
  2. Certificates
  3. P25143 Certificat